Aristopharma Ltd

Our Products

Febux (Febuxostat)

Therapeutic Group : Antigout & DMARD

Share on facebook
Share on twitter
Share on print
Share on email
Febuxostat is a non-purine, selective xanthine oxidase (XO) inhibitor. It decreases serum uric acid level by inhibiting xanthine oxidase, which is responsible for uric acid production. Xanthine oxidase breaks down hypoxanthine to xanthine and thus to uric acid. Febuxostat is not expected to inhibit other enzymes involved in purine and pyrimidine synthesis and metabolism at therapeutic concentrations.